相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth
Andreas Wicki et al.
CLINICAL CANCER RESEARCH (2012)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters
Elena A. Dubikovskaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients
Isa E. L. M. Kuppens et al.
CLINICAL CANCER RESEARCH (2007)
Pharmacological strategies for overcoming multidrug resistance
S. Nobili et al.
CURRENT DRUG TARGETS (2006)
EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells
Christoph Mamot et al.
JOURNAL OF DRUG TARGETING (2006)
The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1
R Abdul-Ghani et al.
ONCOGENE (2006)
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo
C Mamot et al.
CANCER RESEARCH (2005)
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma
L Pusztai et al.
CANCER (2005)
Development of ligand-targeted liposomes for cancer therapy
CO Noble et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Liposome-based approaches to overcome anticancer drug resistance
C Mamot et al.
DRUG RESISTANCE UPDATES (2003)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
H Bier et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
The (patho)physiological functions of the MRP family
J Renes et al.
DRUG RESISTANCE UPDATES (2000)
分享论文
